Echo Therapeutics, Inc. (ECTE)
ECTE has a market cap or net worth of $72,025. The enterprise value is $3.20 million.
ECTE has 13.30 million shares outstanding. The number of shares has increased by 4.28% in one year.
|Shares Change (YoY)||+4.28%|
|Shares Change (QoQ)||+1.37%|
|Owned by Insiders (%)||n/a|
|Owned by Institutions (%)||n/a|
The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 0.06, with a Debt / Equity ratio of n/a.
|Debt / Equity||n/a|
|Debt / EBITDA||-0.63|
|Debt / FCF||-0.66|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||-1,055.40%|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$658,150|
In the past 12 months, ECTE has paid $3,420 in taxes.
|Effective Tax Rate||-0.03%|
Stock Price Statistics
The stock price has decreased by -97.50% in the last 52 weeks. The beta is 6.78, so ECTE's price volatility has been higher than the market average.
|52-Week Price Change||-97.50%|
|50-Day Moving Average||0.00|
|200-Day Moving Average||0.03|
|Average Volume (30 Days)||18,725|
Short Selling Information
|Short % of Shares Out||2.06%|
|Short % of Float||2.52%|
|Short Ratio (days to cover)||3.40|
|Net Income Common||-12.50M|
|Earnings Per Share (EPS)||-$1.10|
The company has $390,281 in cash and $3.52 million in debt, giving a net cash position of -$3.13 million or -$0.24 per share.
|Cash & Cash Equivalents||390,281|
|Net Cash Per Share||-$0.24|
|Book Value Per Share||-0.47|
In the last 12 months, operating cash flow was -$5.09 million and capital expenditures -$270,165, giving a free cash flow of -$5.36 million.
|Operating Cash Flow||-5.09M|
|Free Cash Flow||-5.36M|
|FCF Per Share||-$0.40|
Dividends & Yields
ECTE does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The last stock split was on June 7, 2013. It was a reverse split with a ratio of 1:10.
|Last Split Date||Jun 7, 2013|